AstraZeneca, Juno Recently Teamed Up To Develop Immuno-Oncology Therapies

April 23, 2015 5:05 PM

16 0

A unit of AstraZeneca Plc has collaborated with Juno Therapeutics Inc to create combination treatments that use the body’s immune system to kill cancer cells.

The partnership between AstraZeneca’s research and development arm MedImmune and Juno is the most recent joint effort between companies aim on developing a new class of medications known as immuno-oncology treatments, considered a breakthrough in cancer treatment.

Read more

To category page